Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom

BACKGROUND: The prognosis for hepatocellular carcinoma (HCC) is dependent upon tumour stage, performance status (PS), severity of underlying liver disease, and the availability of appropriate therapies. The unavailability of sorafenib may have a significantly adverse effect on the prognosis of UK pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Palmer, D H, Hussain, S A, Smith, A J, Hargreaves, S, Ma, Y T, Hull, D, Johnson, P J, Ross, P J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3749577/
https://ncbi.nlm.nih.gov/pubmed/23880824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.410
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados